Results 131 to 140 of about 379,801 (144)

Heterologous ChAdOx1/BNT162b2 Vaccination Induces Stronger Immune Response Than Homologous ChAdOx1 Vaccination: The Pragmatic, Multi-Center, Three-Arm, Partially Randomized HEVACC Trial

EBioMedicine, 2022
Alessandro Sette, Wegene Borena, Jose Mateus   +2 more
exaly  

To Mix or Not to Mix? A Rapid Systematic Review of Heterologous Prime–Boost Covid-19 Vaccination

Expert Review of Vaccines, 2021
Daniel Tsung-ning Huang, Yu-Lin Tai, Nan-Chang Chiu   +2 more
exaly  

Dynamics of Humoral and Cellular Immune Responses After Homologous and Heterologous SARS-CoV-2 Vaccination With ChAdOx1 nCoV-19 and BNT162b2

EBioMedicine, 2022
Kilian Schober, Nina Körber, Matthias Tenbusch   +2 more
exaly  

SARS-CoV-2 Delta Variant Neutralisation After Heterologous ChAdOx1-S/BNT162b2 Vaccination

Lancet, The, 2021
Stefan Pöhlmann, Inga Nehlmeier, Metodi Stankov   +2 more
exaly  

The Case for Catch-Up Human Papillomavirus Vaccination in At-Risk Populations: Rural Communities and Survivors of Pediatric and Young Adult Cancers

Ca-A Cancer Journal for Clinicians, 2020
Allison Grimes, Alec J Kacew, Deanna Teoh   +2 more
exaly  

Safety and Immunogenicity of Heterologous ChAdOx1-nCoV19 and BNT162b2 Vaccination: A Meta-Analysis of the Heterologous COVID-19 Vaccination Outcomes

Vaccine, 2023
Liyun Miao, Yuxuan Hu, Yanning Wang
exaly  

Reply to the Case for Catch-Up Human Papillomavirus Vaccination in At-Risk Populations: Rural Communities and Survivors of Pediatric and Young Adult Cancers

Ca-A Cancer Journal for Clinicians, 2020
Robert A Smith, Debbie Saslow, Elizabeth T H Fontham   +2 more
exaly  

Heterologous Prime Boost COVID 19 Vaccination

Infectious Diseases Now, 2022
O Launay
exaly  

Human Papillomavirus Vaccination Guideline Update: American Cancer Society Guideline Endorsement

Ca-A Cancer Journal for Clinicians, 2016
Lacey Loomer, Robert A Smith, Debbie Saslow   +2 more
exaly  

Human Papillomavirus Genotype Distributions Inform Screening and Vaccination Policy

Ca-A Cancer Journal for Clinicians, 2009
Mary Desmond Pinkowish, M D Pinkowish
exaly